Compound ID | 500
QX-3073
Class: Bacterial topoisomerase inhibitor
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | S. aureus (MRSA and quinolone resistant strains), VRE and S.pneumoniaeare susceptible to this compound |
| Institute where first reported: | Quorex pharmaceuticals, USA |
| Year first mentioned: | 2004 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.